Nasdaq: SYRE
Spyre Therapeutics insiders
The officers, directors and 10% owners of Spyre Therapeutics, Inc. who hold the most stock, valued at the live SYRE price.
$97.63
SYRE today −$3.8M (−3.77%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their SYRE stock
- $67.3M
- Market value
- $9.27B
- Held by ranked insiders
- 0.73%
Insiders by value of SYRE holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Cameron Turtle | Chief Executive Officer | 537,540 | $52.5M | 0.57% | 2428th |
| 2 | Scott L. Burrows | Chief Financial Officer | 79,762 | $7.8M | <0.1% | 9209th |
| 3 | Michael Thomas Henderson | Director | 68,606 | $6.7M | <0.1% | 11773rd |
| 4 | Marcio Souza | Director | 3,600 | $351K | <0.1% | 5468th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Spyre Therapeutics; see each profile for the filing.